scorecardresearch
Add as a preferred source on Google
Wednesday, January 7, 2026
TopicFDA

Topic: FDA

Op Broader Sword: India, US join hands to crack down on shipments of ‘illicit’ drugs, medical devices

Operation targeted packages entering US from India through New York (JFK) & Chicago (ORD) International Mail Facilities (IMFs) last month. Over 500 shipments seized, Indian national held.

After Singapore, US now approves sale of lab-grown meat in restaurants, grocery stores

The US government’s approval to two California-based companies is being seen as a huge step for the alternative protein industry.

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

On Camera

A 2-hour op, precise extradition—what Maduro’s capture tells us about modern US military

Despite multiple agencies being involved, the US could maintain a clear chain of command. This is something India should consider too, as it defines the theatre command structures.

Trump threatens India with fresh tariffs on Russian oil, calls PM Modi a ‘good guy’

The latest comment comes as New Delhi and Washington have yet to sign a trade agreement. India’s purchase of Russian oil has reduced, but Moscow remains top source for crude.

S-300, Su-30 jets, T-72 tanks: Inventory of Venezuela’s largely Russian-origin arsenal

Venezuela also boasts of a diverse portfolio of unmanned aerial vehicles capable of carrying out surveillance, reconnaissance and being employed for kinetic purposes as well.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.